Saint Louis, Missouri
Objedives. We tested tbe bypotbesis tbat penxat ackieved of predkted peak oxygen uptake (predicted %'o+ax) impnwes tbe prognostic accuracy of identitjing bigb risk ambolatary patients with congestive beati fuibue conddered for beart tiansplantatiun compared with abwlate peak osygea aptake &+ax) in 181 patients witb iscbemic or dilated cardiomyapatby.
5ackgrwund. Congestive hean failure is the leading diagnosis and cause of cardio~~at morbidity and mortality reported in recen: years, with 1 to 2 milliin Americans affected (1) . Despite significant advances in medical therapy and the use of angiotensinconverting enzyme inhibitor drugs, the survival of patients with moderate to severe congestive heart failure remains limited (2, 3) . Heart transplantation enhances survival in seiected patients who have severely depressed left ventricular ejection fraction, with an 80% to 90% l-year survival (4), significantly better than survival of historic controi patients on optimal medical therapy (3,!5,6) . This has led to increased referrals to heart transplantation programs. However, the limited number of heart donors has increased the interval preceding transplantqtion, adversely influencing patient outme (7) . Several clinical, hemodynamic and exercise criteria have been pm posed to identib high risk patients referred for heart transplantation (8-11). Peakexercise oxygen uptake (ir$max) cl4 ml/kg per min is one exercise variable reported to predict mortality in patients with congestive heart failure with a l-year sumiwJ of -7O%, sign&candy Ia than patients with exercise capacity >14 ml/kg per min (12).
Peak oxygen uptake % inffuenced by age, gender and bo& weight (13) (14) (15) (16) (17) (18) . The use of an exercise variable that adjusts for these factors may further improve the prediiive accuracy of the iro,max variable in the risk stratification process. Dilated cardiomyopathy is reported to have a better outcome than ischemic cardiomyopathy (5); however, the prediie value of cardiilmonary exercize testing in these two patient subsets is not known. Therefore, we tested the hypotheses that 1) the use of the percent achieved of predicted vm which accounts for age, gender an$ weight. enhances the risk stratification of ambulatory patients ev&ated for heart transplantation cmpared with the use of absolute ,$+max alooe;
2) the determination of percent predicted Vo,max and Vo2max arc predictii of outcome events whether the etiology 6 is&mic cardiomyopathy or notlischemie&~ cardie
Methods
Between April 1991 and June 1993,181 consecutive ambulatory patients referred to the Heart Failure Program at Saint Louis University Health Sciences Center were evaluated (146 men, 35 women; mean [?SD] age 49 2 IO years, range 21 to 68 years). The etiology of heart failure was coronary artery disease in 94 patients (52%) and dilated cardiomyopathy in 87 (48%) (idiopathic in 79, valvular in 5, congenital in 3). Previous my-dial infarction was reported in 81 patients (45%); 56 (31%) had history of hypertension; 31 (17%) had history of diabetes mellitus; and 105 (58%) had a history of smoking. All patients were in New York Heart Association functional classes II to III. Rest left ventricular ejection fraction was determined from left ventriculography or radionuclide angiography during the initial evs!ueticn. Rest haweline hemodynamic dat, were obtained from right heart catheterization using Swan-Ganz catheters; cardiac output was determined by thermodilution technique.
Cardiopulmonary exercise testing. Symptom-limited cardiopulmonary exercise testing with respiratoty gas exchange analysis was performed in 181 patients after written informed consent had been obtained. The modified Bruce protocol was used in 144 patients (So%), and the modified Asymptomatic Cardiac Ischemic Pilot (19) or modified Naughton protocol was used in the remaining 37 (20%). Patients with rest or crescendo angina pectoris were excluded. All patients with ischemic etiology were not candidates for revascularization. Standard 1Zlead electrocardiograms were obtained at rest, each minute during exercise and for 5 min into the recovery phase while blood pressures were measured using a standard cutI sphygmomanometer. Leveis of mixed expired oxygen, carbon dioxide and ventilation were determined at rest and every 30 s using a Medical Graphics Corporation 2001 or Cardio, metabolic cart. Anaerobic threshold was defined as the Voz at which expired carbon dioxide increased nonlinearly relative to oxygen consumption (V-slope) (20). The Vozmax was defined as the highest Voz rate observed during exercise.
Age-and gender-adjusted predicted Voz was determined using the treadmill equations of Wasserman et aI. Fdlow-op. All patients were followed up by the Heart Failure Unit at Saint Louis University Health Sciences Center, and data Iiom clinic visits, medical records review or telephone interview were recorded. Cardiac deaths within 24 h of acute symptoms heralded by abrupt loss of consciousness were considered sudden, whereas those resulting from progressive symptomatic or hemodytiamic deterioration were clas.sihed as progressive heart failure. Status 1 patients were defined as those 'patients who required intensive care unit admission and prolonged inotropic or mechanical cardiovascular support. canliac--relaied events were delined as cardiac death or the composite end point of cardiac death or Status 1 transplant priority.
Statistical analysis. Intergroup digerences among clinical, hemodynamic and exercise variables were compared using unpaired I tests or chi-square analysis where appropriate. A p value <0.05 was considered statistically significant. hi Cox proportional hazards model was used to measure the impact of clinical history and test results on time to cardiac event. Separate analyses were performed for the end point of cardiac death and cardiac death or change to Status 1 transplant priority. The cardiac event was coded as a binary event, with time to follow-up coded in months. Univariate analysis of baseline clinical, hemodynamic, angiographic and exercise variables was performed for the end points of cardiac death and cardiac death or Status 1 transplant priority. Multivariable regression analyses were performed on significant univariate predictors with p < 0.2 (23). Variables examined were ~50% predicted Vo,max, Vozmax 514 ml/kg per min, history of myocardial infarction, male gender, functional class, smoking history and triple conventional medical therapy. Modeloverhtting procedures were examined, that is. plots for the effect of influential cases and ratio of outcome events to number of independent variables (24). The proportional hazards assumption was satisfied for each regression model.
Receiver operating characteristic (RGC) curves (True Epistat, Version 5.0, Epistat Services) were constructed by plotting true positive rates (sensitivity) against false positive rates (1 -specificity) to compare discriminatory accuracy for survival and event-free survival for percent predicted Vozmax among the equations of Wasserman et al. (?l), Jones et al. (22) and Bruce et al. (17) and Vozmax. The ROC curves were compared using the z statistic (25). The area under the ROC curve is a measure of the discriminatory accuracy of a variable in I-"?ing outcome. A test with a high sensitivity and specificity will produce a curve shifted up and to the left compared to a test providing random estimates that will produce a 45" line. The area under the curve can range from I to 0, with 1 being perfect discrimination, 0.5 having no more discrimination than random chance and 0 being perfect incorrect discrimination.
Results
The clinical characteristin and hemodynamic and exercise data of the study patients are presented in Table 1 . The mean percent predicted Vozmax for all patients was 54 -C 19%. The mean Vc,max was 16.3 -C 5.9 ml/kg per min. Anaerobic threshold could not be detemllned in 16 patients; peak respiratory exchange ratio (r) was >l.O in these patients. There were no complications as a result of the exercise test procedure.
After 12 + 6 months of follow-up, 44 patients (24%) experienced an event (cardiac death, Statss I). Of 26 patients wt., died, 12 had a sudden cardiac death, and 14 died of progressive heart railure. Twenty deaths occurred in patients with coronary artery disease. Thiifrve patients received a heart transplant. Eighteen patients were listed as Status 1, and 17 were listed as Status 2 priority for heart transplantation. 'Ihe ~prcsen~aremeanvaluerSDornumber(c/r)ofpailents(Pts).CAD=awo~~yarte~~.~F=~~r bean failure; CI = eardiae index; CCte = carbm dii DCM = dilated car-LVEF = kft\emrmdar qexzkn fractia; NYHA = New York Heart Association: PCWP = puhnorwy capillary zedge prewte: "U'Piio, = percent z&e& Or predicted peak oxygen uptake (Wascrntae et at. [?I1 fcrmula); PVo, = peak oxvgn uptake.
clinical and hemodynamic characteristics between survivors and nonsurvivors are summarized in Table 2 .
Comparison of cardiopulmonary exercise variables between nonsurvivors and survivors is displayed in Table 3 . Nonsurvi- vors achieved a lovver percent predicted i'o,max (38 I ltl'i vs. 57 2 180/c, p < OMJOl) and ke; ~'O~IEW (I? + 4 vs. 17 t 6. p < O.oOOl) than survivors.
Mnl~ models. Multivariable models to predict cardiac death and cardiac death or Status 1 w-ere run to examine important baseline and exercise variables ( Table 4 ). The only independent predictor of cardiac death was 9+tl% predicted irormax (p = 0.007); ~50% predicted Vo,max (p = 0.0005) and functional class (p = 0.04) were indeperdent predictors of cardiac events. Survival was assessed using cSO% and >50% predicted iro,max as a cut point. The 80 patie,lts who achieved ~50% predicted ir,,max had a significantly worse survival than the 92 patients who achieved :50% predicted voiro,max (p = 0.001) (Fig. 1) . When survival of the 92 heart failure patients who achieved HO 7c predicted ?3,max was compared with that of 35 patients who underwent heart transplantation, the 2-year survival rates were 90% and 8Y%, respectively (p = h's). Similar survival rates were observed when patients were dratitied using iro,max 514 (n =-70) and >14ml/kg per min (n = 111) (p = 0.001). Separate analyses for the combined end point of cardiac death or Status 1 revealed a greater event rate in patients unable to achieve SO% predicted *o,max (p < 0.0001) (Fig. 2) . The results were similar using a cut point of 514 and >14 ml/kg per min (p < 0.0001). Although both percent predicted \io,max and iro,max were significant predictors of cardiac events, the percent predicted iro,max predicted 10 more events (4 cardiac death, 6 Status 1) than Vo,max (n = 38 vs. n = 28). Table 6 . The optimal cut point for percent predicted \io,max was 50%. The sensitivity to predict cardiac death for ~50% predicted \jnLznax old vo2max cl4 was 92% and 77%, respectively, and specificity was 58% and 68%. Similarly, the sensitivity for CiO% predicted vo,max was higher than iro2max 514 when the combined end points of cardiac death or Status 1 were analyzed (86% vs. 68%). with similar specificity (63% vs. 6%). The overall discriminatory accuracy using ROC analysis for percent predicted vo2max (0.78) was significantly greater than that for vo,max (0.72) (p = 0.036) for cardiac-related events (Fig. 3) . The difference was not significant for cardiac death (0.82 vs. 0.78, p = 0.15).
AnaIysIs aecordIng to heart faRare typo Separate inivariate and Cox multivariable analyses of the 94 patients with coronary artery disease and 87 patients with dilated cardiomyopathy were performed to examine the impact of etiology on outcome. In the 94 patients with coronary artery disease etiology, ~50% predicted iro,max, \io,max 514 and triple conventional medii therapy were significant univariate predictors (p < 0.2) (23) of both cardiac death and cardiac death or Status 1. When these variables were entered into 3 multivariable model, 550% predicted iro,max was the only remaining independent predic$or of cardiac death (p = 0.04) or any cardiac-related event (p = 0.02). The 20 patients with coronary artery disease who died had 3 significantly lower percent When the 87 patients with dilated cardiomyopathy etiology were examined, 150% predicted iro,max, iro2max cl4 and functional class were the only significant univariate predictors for the combined end point of cardiac death or Status 1. When these variables were entered into a multivariable model, 150% predicted ird,max was the only remaining independent predictor (p = 0.02). The six patients with dilated cardiomyopathy who died had a significantly lower percent predicted iro,max (36 -C 9% vs. 63 ?z 20%, p = 0.002) and lower iro,max (12.5 + 1.9 ml/kg per min vs. 18.9 _f 65 mI/kg per min, p = 0.02) than survivors. The differences were simi!ar when the combined end point of cardiac death or Status 1 priority was analpd.
Discussion
The incidence of congestive heart failure is increasing despite an observed decline in coronary artery disease mortality (1,26). The median survival of patients with severe congestive heart failLie is 2 to 3 years (27) . Risk stratification of ambulatory congestive heart failure patients is primarily based on subjective me%ures such as clinical and hmctional ilssessment and rest hemodynamic data. The use of exercise toIerante evaluation in these patients provides an ob+?ive method to identiry patients at higher risk of cardii death and provides long-term prognostic information. The data are useful in selecting patients who could potentially benefit from heart transplantation (12).
Our data show that the use of cardiopuhnomuy exercise testing and determination of the percent achieved of pred&ed \iozmax is a bigbiy accurate predictor both in identifying patients at risk for future cardiac events (cardiac death or Status 1) and in identifying Iow risk patients who can be followed up clinically and maintained on medicaI thew with relatively low mortality or morbidity. Our data confirm eartier results on the value of i$max as 3 useful predktor of mortality and morbiity (5, 8, 12 ). However, percent predicted i$max and the cut point 550% pmdicted iro,max are more sensitive in detecting events then the use of absolute V~rnaq which do& not adjust for age, weight or gender.
previoasshdios CiAnetaL(28)reportedintheDepaC ment of Veterans Affairs &operative
Vasodiiator-Heart
Failure Trials (V-Hem I,II) tbat ejectioa fix&on, cardiotboracic ratio aud iro,max were independeot pxdictors of all-cause mortality. When Vqnax was 514.5 m&g per min, sun+val rates were signilicantly k tban in patients with Vo$nax >14.5 ml/kg per min. In the V-HeFT I trial, irc+max only added signiticant independent prognostic informatxon in the p3tientsubsetkitb3me&nejectbnfmctim>028.Inbot.h V-Hem 1 (n = 642) and V-Hem II trials (n = %04), the wmt smiv3lrateswereobsefvedinmcntithakftven~ ejection fraction 10.28 a+ '&rnax 914.5 n&kg per min.
3.50
!Tl'ELKEN ET AL. OXYGEN UPTAKE IN EXERCISE TESTING death after 11 2 9 months in 122 patients referred for cardiac transplantation evaluation. Patients with Vo,max <14 mI/kg per r&n who were accepted for transplantation had a l-year survival of 70% compared to I-and 2-year survival of 94% and &I% in patients exceeding 14 ml/kg per min. The results are comparable to our observations using percent predicted Vqmax with patients achieving ~50% predicted Vormax having a l-and 2-year survival of 74% and 43% versus l-and 2-year survival of 98% and 90% in patients who achieved >50% predicted Vormax. The latter group had survival at 1 year si$lar to 35 patients who underwent heart transpls*?'ation. Likoff et al. (5) studied 201 patients with congestive heart failure with a mean follow-up of 10.8 t 9 months and reported that patients with Vqmax 513 ml/kg peg min had a substantially higher m,rtality rate than the 15% 1-year mortality in patients who exceeded 13 ml/kg per min.
Parameshwar et al. (8) reported on 127 patients with chronic heart failure who underwent cardiopulmonary exercise testing with 14.6 months of follow-up; total and event-free survival in patients with Vormax ~13.7 ml/kg per min was -70% and 45% compared with -85% and 60% in patients with Voamax >13.7 ml/kg per min.
!klection ati value of pennt achieved of predicted v%max. We selected 50% to enhance the sensitivity of predicting occurrence of cardiac events, a desirable feature of any screening test. The percent achieved of predicted Vo,max was the strongest predictor for cardiac death and cardiac death or Status 1 listing by multivariable analysis.
The data indicate that correction for factors that inherently affect Vormax duting exercise using the equation of Wasserman et al. (2i), \-.1&h accounts for age, gender and body weight, enhances t ;e predictive accuracy of cardiopulmonary exercise testing in risk stratification of ambulatory patients with congestive heart failure, whether the etiology is secondary to ischemic heart disease or dilated cardiomyopathy. Similar results can be achieved with other formulas that adjust for age and gender onIy (17, 22) . Although we examined only three formulas to derive percent predicted Vo,max in this study, other equations can also be used to derive percent predicted Vqmax (29, 30) . fhmparis~n with other prediirs.
The predictive accuracy of clinical and hemodynamic variables was tested for their prognostic value in detecting future cardiac events. Functional CIRSS was the only significant clinical variable in multivariable analysis ( Table 4 ). The clinical findings are at variance with other studiis that report right atrial pressure >12 mm Hg (31) plasma sodium Cl38 mmol/liter (8) and left ventricular ejection fraction <17% (8) as significant multivariable"predictors of death. Griffin et al. (32) reported on 49 patients with chronic congestive heart failure who underwent rest and exercise hemodynamic evaluation. The l-year mortality was 33%. Rest' pulmonary artery wedge pressure and peak exercise stroke work index were the only independent mortality predictors Differences in exercise duration or Vormax achieved between SmVi#rS and nonsurvivors were not sign&ant. The number of ptiettt~ in thii series was small, and a type II error cannot be JACC Vol. 27, No. 2 February !996345-52 excluded. Pulmonary capillary wedge pressure was a univariate predictor in our series but was not selected after exercise, results were entered into the model. The type of exercise performed (bicycle exercise) and the inclusion of patients with functional ,class IV heart failure in the study by Griffin et al. (32) (25% of participants) may also explain the differences observed.
In patients with congestive heart failure, coronary artery disease adversely affects prognosis (33) . Thus, exercise outcome predictors such as percent predicted Vo,max or Voo,max may potentially be influenced by the type of patients with congestive heart failure selected for study. In the SOLVD trial (34) Vozmax did not differ between subjcsts with ischemic (n = 139) and nonischemic heart disease (n = 25); Vo,max did correlate significantly with age and gender. In our series of 94 patients with ischemic cardiomyopathy and 87 patients with nonischemic dilated cardiomyopathy, percent predicted Vo,max was significantly different between the two types of cardiomyopathy and was a useful variable in predicting out come in both groups. The magnitude of prognostic separation was greater in the ischemic cardiomyopathy group.
Study limitations. The study cohort represents a large group of patients with congestive heart failure. Approximately half of the study cohort had ischemic cardiomyopathy, and the remainder had nonischemic dilated cardiomyopathy. The inclusion of the two different types of cardiomyopathy could have influenced the results. However, both patient groups share many similarities in their clinical, hemodynamic and therapeutic characteristics at the time of exercise testing, and we have shown the prognostic utility of cardiopulmonary exercise testing in both groups. The small number of cardiac deaths (n = 6; 7%) in the 87 patients with dilated cardiomyopathy precludes an in-depth prognostic assessment of this subgroup. Additional prospective studies with a larger series of patients with dilated cardiomyopathy are needed to substantiate the prognostic value of percent predicted Vo,max in this cohort.
The use of previously published data regarding age-, gender-and weight-adjusted Vo2max as a control value to derive the percent predicted oxygen uptake rate may not be the optimal method to determine the degree of exercise capacity impairment. However, the formulas are derived from large cross-sectional studies and represent a normal population, which we believe justifies the use of these data to represent a hypothetica! control group. We tested our hypotheses for percent predicted Vo,max using other published predicted Vo,max formulas (17, 22) and found that the results were not significantly influenced by Choice of reference group.
We did not study a large group of women (n = 35) in our study, and the small number of events observed (n = 3) precludes firm conclusions regarding impact of gender on survival.
A potential limitation is the use of different exercise protocols in this study. However, analysis of the 144 patients who performed cardiopidmonary testing using the modified Bruce protocol gave similar results to patients who performed a non-Bruce protocol. The protocols used were compared in our laburatory in normal subjects and in patients with coronary artery disease (19). Peak oxygen uptake rate values were similar regardless of exercise protocol used. Chid implications.
The present report extends previous observations of the significant predictive value of cardiopulmonary exercise testing in the risk stratification of patients with severe congestive heart failure. The use of 30% predicted iro,max provides prognostic information additional to the absolute iro,max and can eliminate the potential influence of factors such as age, gender, and weight on the predictive accuracy of the test. Our data demonstrate that patients who receive optimal medical therapy and have preserved exercise capacity can continue to be followed up clinically and undergo serial cardiopulmonary exercise testing to determine the optimal time and potentially prevent adverse outcomes, although this hypothesis needs to be tested prospectively. This approach can assist in decreasing the waiting time for patients awaiting heart transplantation by optimizing the selection process.
